Revolutionising cellular therapies for cancer and beyond

We’re developing more precise and more accessible treatment options for patients with solid cancers, endometriosis and Alzheimer’s disease

Pioneering excellence in the field of immunotherapy

Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers, endometriosis and Alzheimer’s disease. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer and beyond.

Learn more about us

Some of our partners

Latest news

Message from the CEO

By Christine Filippis / December 16, 2024
As we reflect on 2024, it's clear that this year has been a defining chapter in Cartherics' 10-year history. We've...
Read More

BioSpectrum Asia: “Moving forward, cancer may not be a death threat but a manageable disease with strong control”

By Christine Filippis / November 6, 2024
Cartherics’ CEO, Prof. Alan Trounson was recently interviewed by BioSpectrum Asia discussing the development of the company’s cell-based immunotherapies for...
Read More

Cartherics is “Frocking Up” this month to support ovarian cancer research

By Christine Filippis / October 30, 2024
Cartherics is frocking up this October to raise funds and awareness for crucial ovarian cancer research. The current five-year survival...
Read More